AI English summary of an SEC filing — figures as filed
Agilent Technologies AAgilent said net revenue for 2025 was $6,948 million, an increase of 7% compared to 2024. The company said foreign currency movements had no impact on revenue growth and revenue from the BIOVECTRA acquisition contributed approximately 2 percentage points.
Key points
AI summaryAgilent said net revenue for 2025 was $6,948 million, an increase of 7% compared to 2024. The company said foreign currency movements had no impact on revenue growth and revenue from the BIOVECTRA acquisition contributed approximately 2 percentage points.
Agilent said net income for 2025 was $1,303 million, compared to $1,289 million in 2024 and $1,240 million in 2023. The company said net income in 2025 was favorably impacted by several tax benefits that reduced its overall tax provision.
Agilent said net cash provided by operating activities for 2025 was $1,559 million, lower than $1,751 million in 2024. The company said investments in property, plant and equipment in that year were $407 million and anticipated capital expenditures for fiscal 2026 are approximately $500 million.
Agilent said it repurchased and retired 3.4 million shares for $425 million in 2025 and paid cash dividends of $282 million. The company said remaining authorization to repurchase common stock under the 2024 repurchase program as of October 31, 2025 was approximately $1.9 billion.
Key figures
Fiscal year ended October 31, 2025
- Revenue
- $6.9B
- Operating income
- $1.5B
- Net income
- $1.3B
- EPS
- $4.57
- Operating cash flow
- $1.6B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Annual net revenue $6,948 million, up 7% from prior year
Agilent said net revenue for 2025 was $6,948 million, an increase of 7% compared to 2024. The company said foreign currency movements had no impact on revenue growth and revenue from the BIOVECTRA acquisition contributed approximately 2 percentage points.
Source · Based on the MD&A text of the filing
Net income $1,303 million and tax benefits cited by the company
Agilent said net income for 2025 was $1,303 million, compared to $1,289 million in 2024 and $1,240 million in 2023. The company said net income in 2025 was favorably impacted by several tax benefits that reduced its overall tax provision.
Source · Based on the MD&A text of the filing
Operating cash flow $1,559 million, 2025 capital expenditures $407 million
Agilent said net cash provided by operating activities for 2025 was $1,559 million, lower than $1,751 million in 2024. The company said investments in property, plant and equipment in that year were $407 million and anticipated capital expenditures for fiscal 2026 are approximately $500 million.
Source · Based on the MD&A text of the filing
2025 share repurchases and dividends, 2024 repurchase program remaining authorization
Agilent said it repurchased and retired 3.4 million shares for $425 million in 2025 and paid cash dividends of $282 million. The company said remaining authorization to repurchase common stock under the 2024 repurchase program as of October 31, 2025 was approximately $1.9 billion.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…